These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1290721)

  • 1. Antitumor effect of a Coliolus preparation, PSK: induction of macrophage chemotactic factor (MCF) in spleens of tumor bearing mice.
    Ishikawa K; Majima T; Ebina T
    Biotherapy; 1992; 5(4):251-8. PubMed ID: 1290721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differences of antitumor effect of various BRMs by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.
    Ebina T; Murata K
    Jpn J Cancer Res; 1990 Dec; 81(12):1307-13. PubMed ID: 2126000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
    Ebina T; Kohya H
    Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effect of intratumoral administration of a Coriolus preparation, PSK: inhibition of tumor invasion in vitro].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2241-3. PubMed ID: 7944450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PSK on interferon production in tumor-bearing mice.
    Kitani H; Tsuru S; Oguchi M; Watanabe M; Zinnaka Y
    J Clin Lab Immunol; 1984 Dec; 15(4):211-4. PubMed ID: 6084715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
    Ebina T; Kohya H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.
    Ebina T; Murata K
    Jpn J Cancer Res; 1992 Jul; 83(7):775-82. PubMed ID: 1517151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of PSK on Th1/Th2 balance in tumor-bearing mice].
    Wada T; Iijima H; Sekine F; Kato M; Tsugane M; Oguchi Y; Matsunaga K; Ando T; Nomoto K
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1798-801. PubMed ID: 14619523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Krestin (PSK) on the induction of IL-2 activated killer cells.
    Sakamaki S; Kohgo Y; Nojiri S; Kanisawa Y; Ito Y; Takahashi M; Ueno Y; Hirayama Y; Niitsu Y
    Jpn J Clin Oncol; 1992 Apr; 22(2):79-83. PubMed ID: 1619782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
    Ebina T; Kohya H; Ishikawa K
    Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-bound polysaccharide-K reduces the proportion of regulatory T cells in vitro and in vivo.
    Aoki R; Iijima H; Kato M; Uchida M; Wada T; Murata M; Ogawa K; Naritaka Y; Yoshimatsu K
    Oncol Rep; 2014 Jan; 31(1):50-6. PubMed ID: 24190620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
    Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effector mechanism of interleukin-1 beta at a distant site in the double grafted tumor system.
    Ebina T; Murata K
    Jpn J Cancer Res; 1991 Nov; 82(11):1292-8. PubMed ID: 1752785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor effects of intratumoral injection of Basidiomycetes preparations].
    Ebina T
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1654-6. PubMed ID: 16315899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of biological response modifiers with different modes of action used separately and together on immune responses in mice with syngeneic tumours.
    Matsunaga K; Morita I; Iijima H; Endoh H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
    J Int Med Res; 1992 Sep; 20(5):406-21. PubMed ID: 1280606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of a protein-bound polysaccharide, PSK, against Candida albicans infection in syngeneic tumor-bearing mice via Th1 cell functions.
    Ohmura Y; Matsunaga K; Motokawa I; Sakurai K; Ando T
    Cancer Biother Radiopharm; 2003 Oct; 18(5):769-80. PubMed ID: 14629825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice.
    Harada M; Matsunaga K; Oguchi Y; Iijima H; Tamada K; Abe K; Takenoyama M; Ito O; Kimura G; Nomoto K
    Int J Cancer; 1997 Jan; 70(3):362-72. PubMed ID: 9033641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.